{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:10:06Z","timestamp":1747818606213,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,21]]},"DOI":"10.7759\/cureus.84522","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:35:18Z","timestamp":1747816518000},"source":"Crossref","is-referenced-by-count":0,"title":["Gliomas Uncovered: A Deep Dive Into Immunohistochemical and Molecular Features From a Tertiary Care Facility Perspective"],"prefix":"10.7759","author":[{"given":"Pratiksha","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Mohapatro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyani P","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakir  C","family":"Munda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lity","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis DN","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, et al.. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114:97-109. 10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jnen.0000263869.84188.72","article-title":"Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome","volume":"66","author":"Kros JM","year":"2007","unstructured":"Kros JM, Gorlia T, Kouwenhoven MC, et al.. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome. J Neuropathol Exp Neurol. 2007, 66:545-51. 10.1097\/01.jnen.0000263869.84188.72","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0725-7","article-title":"Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective","volume":"120","author":"van den Bent MJ","year":"2010","unstructured":"van den Bent MJ. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective. Acta Neuropathol. 2010, 120:297-304. 10.1007\/s00401-010-0725-7","journal-title":"Acta Neuropathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","author":"Louis DN","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, et al.. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. 2016. 10.1007\/s00401-016-1545-1"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1215\/S1522851705000268","article-title":"Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area","volume":"8","author":"Wrensch M","year":"2006","unstructured":"Wrensch M, Rice T, Miike R, McMillan A, Lamborn KR, Aldape K, Prados MD. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro Oncol. 2006, 8:12-26. 10.1215\/S1522851705000268","journal-title":"Neuro Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0715","article-title":"IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas","volume":"15","author":"Nobusawa S","year":"2009","unstructured":"Nobusawa S, Watanabe T, Kleihues P, Ohgaki H. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res. 2009, 15:6002-7. 10.1158\/1078-0432.CCR-09-0715","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan H","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, et al.. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009, 360:765-73. 10.1056\/NEJMoa0808710","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181c391be","article-title":"Diagnostic use of IDH1\/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues","volume":"68","author":"Horbinski C","year":"2009","unstructured":"Horbinski C, Kofler J, Kelly LM, Murdoch GH, Nikiforova MN. Diagnostic use of IDH1\/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues. J Neuropathol Exp Neurol. 2009, 68:1319-25. 10.1097\/NEN.0b013e3181c391be","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.538","article-title":"TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations","volume":"111","author":"Labussi\u00e8re M","year":"2014","unstructured":"Labussi\u00e8re M, Di Stefano AL, Gleize V, et al.. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. Br J Cancer. 2014, 111:2024-32. 10.1038\/bjc.2014.538","journal-title":"Br J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow JE","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, et al.. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015, 372:2499-508. 10.1056\/NEJMoa1407279","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0351-2","article-title":"A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas","volume":"4","author":"Arita H","year":"2016","unstructured":"Arita H, Yamasaki K, Matsushita Y, et al.. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016, 4:79. 10.1186\/s40478-016-0351-2","journal-title":"Acta Neuropathol Commun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12432","article-title":"WHO 2016 classification of gliomas","volume":"44","author":"Wesseling P","year":"2018","unstructured":"Wesseling P, Capper D. WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol. 2018, 44:139-50. 10.1111\/nan.12432","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033449","article-title":"Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma","volume":"7","author":"Christians A","year":"2012","unstructured":"Christians A, Hartmann C, Benner A, et al.. Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. PLoS One. 2012, 7:e33449. 10.1371\/journal.pone.0033449","journal-title":"PLoS One"},{"key":"ref14","article-title":"Microsatellite instability and DNA methylation of endometrial tumors and clinical features in young women compared with older women","volume":"20","author":"Zauber NP","year":"2010","unstructured":"Zauber NP, Denehy TR, Taylor RR, et al.. Microsatellite instability and DNA methylation of endometrial tumors and clinical features in young women compared with older women. Int J Gynecol Cancer. 2010, 20:1549-56.","journal-title":"Int J Gynecol Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700664","article-title":"MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas","volume":"87","author":"Jeuken JW","year":"2007","unstructured":"Jeuken JW, Cornelissen SJ, Vriezen M, et al.. MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab Invest. 2007, 87:1055-65. 10.1038\/labinvest.3700664","journal-title":"Lab Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen X","year":"2022","unstructured":"Chen X, Zhang T, Su W, et al.. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 2022, 13:974. 10.1038\/s41419-022-05408-1","journal-title":"Cell Death Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin N","year":"2011","unstructured":"Rivlin N, Brosh R, Oren M, Rotter V. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer. 2011, 2:466-74. 10.1177\/1947601911408889","journal-title":"Genes Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31827f9c5e","article-title":"Epithelioid GBMs show a high percentage of BRAF V600E mutation","volume":"37","author":"Kleinschmidt-DeMasters BK","year":"2013","unstructured":"Kleinschmidt-DeMasters BK, Aisner DL, Birks DK, Foreman NK. Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol. 2013, 37:685-98. 10.1097\/PAS.0b013e31827f9c5e","journal-title":"Am J Surg Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.12328","article-title":"Analysis of the BRAF(V600E) mutation in central nervous system tumors","volume":"5","author":"Myung JK","year":"2012","unstructured":"Myung JK, Cho H, Park CK, Kim SK, Lee SH, Park SH. Analysis of the BRAF(V600E) mutation in central nervous system tumors. Transl Oncol. 2012, 5:430-6. 10.1593\/tlo.12328","journal-title":"Transl Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.e436","article-title":"Targeting BRAF in pediatric brain tumors","author":"Kieran MW","year":"2014","unstructured":"Kieran MW. Targeting BRAF in pediatric brain tumors. Am Soc Clin Oncol Educ Book. 2014, e436-40. 10.14694\/EdBook_AM.2014.34.e436","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357287-gliomas-uncovered-a-deep-dive-into-immunohistochemical-and-molecular-features-from-a-tertiary-care-facility-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:35:19Z","timestamp":1747816519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357287-gliomas-uncovered-a-deep-dive-into-immunohistochemical-and-molecular-features-from-a-tertiary-care-facility-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84522","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}